154 related articles for article (PubMed ID: 17913970)
1. Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin.
How PP; Fischer JH; Arruda JA; Lau AH
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1235-40. PubMed ID: 17913970
[TBL] [Abstract][Full Text] [Related]
2. Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin.
Kays MB; Overholser BR; Mueller BA; Moe SM; Sowinski KM
Am J Kidney Dis; 2003 Dec; 42(6):1253-9. PubMed ID: 14655198
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study.
Martin P; Wang P; Robinson A; Poole L; Dragone J; Smyth M; Pratt R
Am J Kidney Dis; 2011 May; 57(5):700-6. PubMed ID: 21354682
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
Papich MG
Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin bioavailability is enhanced by oral co-administration with phenazopyridine: a pharmacokinetic study in a Mexican population.
Marcelín-Jiménez G; Angeles AP; Martínez-Rossier L; Fernández S A
Clin Drug Investig; 2006; 26(6):323-8. PubMed ID: 17163266
[TBL] [Abstract][Full Text] [Related]
6. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
[TBL] [Abstract][Full Text] [Related]
7. The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol.
Pierce D; Hossack S; Poole L; Robinson A; Van Heusen H; Martin P; Smyth M
Nephrol Dial Transplant; 2011 May; 26(5):1615-21. PubMed ID: 20921291
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.
Healy DP; Brodbeck MC; Clendening CE
Antimicrob Agents Chemother; 1996 Jan; 40(1):6-10. PubMed ID: 8787869
[TBL] [Abstract][Full Text] [Related]
9. Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin.
Washington C; Hou E; Hughes N; Berner B
Am J Health Syst Pharm; 2006 Apr; 63(7):653-6. PubMed ID: 16554289
[TBL] [Abstract][Full Text] [Related]
10. Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacin.
Lomaestro BM; Bailie GR
Ann Pharmacother; 1993 Nov; 27(11):1325-8. PubMed ID: 8286801
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral administration of fennel (Foeniculum vulgare) on ciprofloxacin absorption and disposition in the rat.
Zhu M; Wong PY; Li RC
J Pharm Pharmacol; 1999 Dec; 51(12):1391-6. PubMed ID: 10678493
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single-dose, two-period crossover study in healthy adult volunteers.
Iqbal Z; Khan A; Naz A; Khan JA; Khan GS
Clin Drug Investig; 2009; 29(4):275-81. PubMed ID: 19301941
[TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability of two brands of ciprofloxacin.
Seth SD; Beotra A; Seth S
J Assoc Physicians India; 1995 May; 43(5):327-30. PubMed ID: 9081961
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic interactions between intravenous ciprofloxacin and oral ferrous sulfate.
Wong PY; Zhu M; Li RC
J Chemother; 2000 Aug; 12(4):286-93. PubMed ID: 10949977
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers.
Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C
Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993
[TBL] [Abstract][Full Text] [Related]
17. Oral ciprofloxacin affects the pharmacokinetics of paracetamol in saliva.
Issa MM; Nejem RM; El-Abadla NS
Clin Drug Investig; 2006; 26(4):223-6. PubMed ID: 17163255
[TBL] [Abstract][Full Text] [Related]
18. A prospective, open-label study of single-dose ciprofloxacin absorption after chemotherapy in patients with malignancy.
Gattis WA; Petros WP; Pickard WW; Drew RH; May DB; Hathorn JW
Pharmacotherapy; 1997; 17(4):836-40. PubMed ID: 9250569
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
